|
MTX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.241500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.660300E-02 |
| Normal-vs-Stage2 |
8.128200E-01 |
| Normal-vs-Stage3 |
2.838700E-04 |
| Normal-vs-Stage4 |
2.06069999999503E-05 |
| Stage1-vs-Stage2 |
9.997900E-02 |
| Stage1-vs-Stage3 |
1.974190E-02 |
| Stage1-vs-Stage4 |
1.758710E-03 |
| Stage2-vs-Stage3 |
3.598800E-03 |
| Stage2-vs-Stage4 |
1.340170E-03 |
| Stage3-vs-Stage4 |
4.301000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.784320E-04 |
| Normal-vs-AfricanAmerican |
4.846400E-01 |
| Normal-vs-Asian |
3.847900E-02 |
| Caucasian-vs-AfricanAmerican |
2.242000E-01 |
| Caucasian-vs-Asian |
4.889400E-01 |
| AfricanAmerican-vs-Asian |
5.410800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.032410E-02 |
| Normal-vs-Female |
9.084000E-03 |
| Male-vs-Female |
7.781600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.995870E-02 |
| Normal-vs-Age(41-60Yrs) |
2.597300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.594450E-01 |
| Normal-vs-Age(81-100Yrs) |
2.893200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.102600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.634400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.385200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.222600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.458400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.899800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.563700E-02 |
| Classical-VS-Follicular |
3.37529999505648E-08 |
| Classical-VS-Other |
2.042000E-01 |
| Classical-VS-Normal |
1.422620E-04 |
| Tall-VS-Follicular |
4.48700000488245E-08 |
| Tall-VS-Other |
4.890400E-02 |
| Tall-VS-Normal |
1.70500999999712E-05 |
| Follicular-VS-Other |
3.920600E-01 |
| Follicular-VS-Normal |
2.102200E-02 |
| Other-VS-Normal |
9.682600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.920790E-01 |
| Normal-vs-N1 |
8.5763000035044E-08 |
| N0-vs-N1 |
2.53760000001879E-06 |
|
|
